Will you be joining my colleagues and me in Utrecht?
#mycompany
Innovators developing technologies for the oral delivery of peptides and proteins: join us in Utrecht or virtually to explore emerging solutions, translational challenges and opportunities for collaboration. Register: jji.jnj/4z24biW
1
22
Calling the next generation of start-up CEOs! Interested in transforming your scientific innovation into a thriving biotech venture? Join a stellar line-up of speakers (and me) in Amsterdam! #mycompany
Join us in Amsterdam or virtually on 31 Oct for "Building a Biotech: Launching and Growing Your Start-up Company." Gain insights from J&J experts and guest speakers on funding, R&D, and more. Don’t miss out–register now: jji.jnj/3zpk1Lb
7
So much of healthcare today is about connecting with the right stakeholders at the right time.
Erik will be a keynote speaker during next week's JLABS program focused on the strategic use of Target Product Profiles.
#mycompany
During drug discovery and development, it is vital to already consider how your product might benefit patients. Read about the importance of ascertaining early how to add value in the future marketplace. jji.jnj/3V1rCYs
7
Interested in a collaboration with J&J? Join this program to learn more about the due diligence process. #mycompany
Does the due diligence process seem daunting?
Don’t miss this chance to get insights from industry experts on how to and set your start-up up for collaboration success!
Register through: jji.jnj/4dtILAX
#JNJInnovation #JLABS #JJIEvent
1
Entrepreneurs and innovators are invited for an in-depth look into different aspects in the journey towards filing a #clinicaltrial application for large molecules. Will you join us in Leiden? #mycompany
Calling all #biotech startups! Join us for a program designed to guide you through the complexities of first-in-human trials for biologics. Gain insights from J&J experts on Preclinical Development, CMC, Trial Design, & Regulatory Strategies. Register: jji.jnj/3uxNos2
9
Interested in collaboration? This program discusses the role of IP in collaborations such as multi-component cellular therapies and vaccines. Will you join me in Leiden? #MyCompany
Your IP strategy may influence opportunities for collaboration. How do you balance the common good of the project with your own interests? Join the hybrid program as different stakeholders share their insights.
#Lifesciences #startups can register here: jji.jnj/3KxWSaN
15
Today at the @I4Hevent Global Investor Forum in Rotterdam, Maria Van Dongen and I provided a workshop on Business Development Basics, during which I also introduced @jnjinnovation @JLABS. Are you interested to discuss collaboration? Let me know!
#mycompany #startups
3
64
It was great to be at @NovioTechCampus to create this video. Nijmegen still feels a bit like home.
@Protinhi, thanks for being a part of this @jnjinnovation @JLABS initiative!
#mycompany @Briskr_
This Post is from an account that no longer exists. Learn more
Are you joining us in Leiden in two weeks' time? I believe this will be a very interesting discussion. #mycompany
This Post is from an account that no longer exists. Learn more
1
Onze oude woning in Lombok (Utrecht) is binnenkort te huur (nee, niet dat hutje op de foto ...). Er zit dan een nieuwe keuken in en de tuin (wel op de foto) blijft fantastisch. Geïnteresseerd!?
123wonen.nl/huur/utrecht/ben…
Niels Wheeler retweeted
#JLABS Global Head @melindarichter joins @NASDAQ Breakthrough Economy to discuss why inclusive access to capital is critical for life science innovation. Watch Melinda here: https://teapaw.org/t.co/HXSWKHP0lf
Niels Wheeler retweeted
We cultivate the European life sciences innovation ecosystem, aiming to enable entrepreneurs to create transformational healthcare solutions. To celebrate our collaborations, we’ve put the spotlight on our innovation network in EMEA.
See more: jji.jnj/3wouRf3
Have you identified your long-term exit strategy? Learn more during this hybrid seminar. #mycompany
Join us on 19 May as @AllenOvery provides a no-nonsense guide to key aspects of exits through M&A, focused on #lifesciences and #medtech #startups.
In-person in Leiden or online: jji.jnj/exit-strategies1
1
Building a stellar team can be a key ingredient of success next to your disruptive invention and fitting funding. #mycompany
Is your #lifesciences #startup looking to expand your team? Join the webinar on 3 March where different stakeholders will share insights in recruiting and retaining talent. jji.jnj/buildingyourteam #recruitment
An organization will never change if the people don't change. To learn more I followed @Prosci training on change management. It was great to learn more about the people side of change. credly.com/badges/46c1c7e1-4…
Great to see @UMCUtrecht from my home town as one of the IDEA #QuickFireChallenge awardees aiming to optimize AL Amyloidosis disease detection: jji.jnj/IDEA #MyCompany
“Time. It’s the single most valuable gift healthcare providers can give their patients.”
Learn how the IDEA #QuickFireChallenge awardees aim to optimize detection of AL Amyloidosis for patients: jji.jnj/IDEA @JanssenGlobal
1
Niels Wheeler retweeted
The first release of Whole Genome Sequencing data for 200,000 @uk_biobank participants is now available. We expect the data will enable a better understanding of the genetic determinants of disease and contribute to accelerating drug discovery work: jji.jnj/3kMCarJ
Niels Wheeler retweeted
Attention UK-based innovators! 🇬🇧 We are looking to connect with start-ups, entrepreneurs and researchers in the pharmaceutical, medical devices and consumer health fields. If this is you, tune in on 30 November to learn how we could work together. 👉 jji.jnj/meetintheuk
Excited for this program taking place on Thursday. It was inspiring to discuss the content with the speakers. #mycompany
Is your #startup considering the needs of patients, partners, prescribers and payers in the development of your healthcare innovation? Innovators are invited to join as we discuss commercial considerations in discovery and early development.
Register: jji.jnj/3jVgB8e
Our webinar on EU grants is happening on Thursday. Do you want to about the experiences of startups in getting non-dilutive funding? Innovators are welcome to join. jji.jnj/3meVyxs #mycompany
For any #startup or small company, non-dilutive #funding may become an essential component of a healthy #financing mix.
Meet Bernd van Buuren from @protinhi and other speakers during this webinar & learn more!
🗓️ 14 October
⏰ 15:00-17:00 CEST
➡️ jji.jnj/3meVyxs
1



















